The Food and Drug Administration has granted an emergency use authorization to a medicine meant to protect certain immunocompromised people against COVID-19.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
